At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
May 10, 2010 valenzano ken Officer Statement of Ownership 0 n/a
May 30, 2007 weinhoff gregory m Director Statement of Ownership 0 n/a
Jun 5, 2007 weinhoff gregory m Director Acquisition (Non Open Market) 1,975,223 n/a
Oct 28, 2008 crowley john f Officer Option Execute 40,000 0.64 - 5.33
Jul 15, 2008 licholai gregory p Officer Option Execute 15,000 0.64
Jul 22, 2008 licholai gregory p Officer Option Execute 15,000 0.64
Aug 18, 2008 licholai gregory p Officer Option Execute 1,401 0.64
Apr 24, 2008 palling david Officer Option Execute 20,000 0.64
Feb 29, 2008 crowley john f Officer Option Execute 10,000 0.64
Jun 21, 2007 crowley john f Officer Option Execute 33,736 0.64
Dec 13, 2007 crowley john f Officer Option Execute 10,000 0.64
Dec 14, 2007 crowley john f Officer Option Execute 5,000 0.64
Jan 2, 2008 crowley john f Officer Option Execute 20,000 0.64
Jan 8, 2009 palling david Officer Option Execute 4,924 0.64
Dec 2, 2008 patterson matthew r Officer Option Execute 20,098 0.64
Feb 21, 2008 patterson matthew r Officer Option Execute 12,083 0.64
Aug 15, 2007 patterson matthew r Officer Option Execute 32,366 0.64
May 24, 2011 valenzano ken Officer Option Execute 2,250 0.64
Mar 30, 2012 crowley john f Officer Option Execute 49,931 0.64
Mar 15, 2013 barer sol j Director Buy 25,000 3.40
Showing 41-60 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy